Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 EUR | -2.38% | +1.23% | +4.13% |
20/05 | Herantis Pharma Submits Clinical Trial Application for A Phase 1B Clinical Trial of Her-096 | CI |
06/03 | Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Herantis Pharma Oyj
Upcoming events on Herantis Pharma Oyj
Past events on Herantis Pharma Oyj
25/04/2024 | Nordic Health Japan Summit |
24/04/2024 | Annual General Meeting |
23/04/2024 | Alzheimers & Parkinsons Drug Development Summit |
06/03/2024 01:00 pm | Q4 2023 Earnings Call |
06/03/2024 11:30 am | Q4 2023 Earnings Release |
24/08/2023 12:30 pm | Q2 2023 Earnings Call |
24/08/2023 10:30 am | Q2 2023 Earnings Release |
01/06/2023 09:30 am | Redeye Growth Day |
20/04/2023 | Annual General Meeting |
02/03/2023 01:30 pm | Q4 2022 Earnings Call |
02/03/2023 11:30 am | Q4 2022 Earnings Release |
17/11/2022 | Carlsquare Nordic Life Science Investor Day |
25/08/2022 12:30 pm | Interim 2022 Earnings Call |
25/08/2022 10:30 am | Interim 2022 Earnings Release |
23/05/2022 | Bio€quity Europe Conference |
22/03/2022 | Sachs Associates Neuroscience Innovation Forum |
03/03/2022 01:30 pm | FY 2021 Earnings Call |
03/03/2022 11:30 am | FY 2021 Earnings Release |
26/08/2021 | Interim 2021 Earnings Release |
15/04/2021 | Annual General Meeting |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,65 |
EBITDA Million EUR | Released Forecast Spread | -6,11 -5,00 -22.17% | -7,14 -6,00 -19.05% | 0,00 | -7,83 -9,00 12.97% | 0,15 -3,00 105.13% | -3,00 |
EBIT Million EUR | Released Forecast Spread | -7,16 -5,66 -26.5% | -8,07 -6,00 -34.52% | 0,00 | -7,99 -9,00 11.19% | 0,15 -3,00 105.13% | -3,95 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -8,00 -6,39 -25.29% | -9,15 -6,00 -52.55% | 0,00 | -9,32 -9,00 -3.6% | 0,28 -3,00 109.33% | -3,20 |
Net income Million EUR | Released Forecast Spread | -8,00 -6,39 -25.29% | -9,15 -6,00 -52.55% | -12,8 | -9,32 -9,00 -3.6% | 0,28 -3,00 109.33% | -3,20 |
EPS EUR | Released Forecast Spread | -1,37 -1,07 -28.64% | -1,24 -0,95 -30.53% | -1,25 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Announcement Date | 27/02/20 | 03/03/21 | 03/03/22 | 28/03/23 | 06/03/24 | - |
Past sector events for Herantis Pharma Oyj
05/06/2024 01:21 pm | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HRTIS Stock
- Calendar Herantis Pharma Oyj